Laboratory capacity for diagnosis of foot-and-mouth disease in Eastern Africa: implications for the progressive control pathway

Table 4 FMD sampling in Eastern Africa

Country/ region	Reporting time for sampling (days)	When sampling is done	Samples collected	Number of samples Collected annually	Duration of transport of samples (days)
Burundi	1-6	AC	Serum, LEF	101-500	1-2
Djibouti	14	SAC	Serum	<100	3
Eritrea	21-30	AC, CH	Serum, LEF	>1000	1-3
Ethiopia	1-6	AC	Serum, LEF, OP	<100	2-7
Kenya	1-6	AC, post V SAC, CH, Res, pre V,	Serum, LEF, OP	101-500	1-2
Puntland	1-6	AC	Serum, LEF, OS	>1000	2-3
Rwanda	1-6	AC	Serum	501-1000	1
Somalia	1-6	AC, SAC	Serum, LEF	>1000	3-4
Somaliland	1-6	AC, SAC	Serum, LEF	>1000	3-4
South Sudan	1-6	AC, SAC	Serum	<100	1-2
Sudan	7	AC, SAC, CH	Serum, LEF, OP	nr	1-3
Tanzania	2-14	AC, SAC, CH, Res	Serum, LEF,OP, OS, WB	101-500	1-2
Uganda	1-6	AC, CH, pre V Res, Sur	Serum, LEF, OP, OS, SA	101-500	1-2

AC: acute phase of outbreak, SAC: sub acute phase of outbreak, CH: chronic phase of outbreak, pre V: pre - outbreak vaccination, post V: post outbreak vaccination, Res: research, Sur: surveillance, LEF: lesion epithelium/fluid, OP: oropharyngeal fluids, OS: oral swabs, SA: saliva, WB: whole blood, nr: NRL did not reply to this question.

ISSN: 1746-6148